Table 3.
Biochemical parameters of different patient groups presented as mean (min; max)
| Fe (μg/dL) | Ferritin (μg/L) | TIBC (μg/dL) | T Bil (mg/dL) | |
|---|---|---|---|---|
| HS | 92.75 (69; 130) | 95.88 (37.4; 166.9) | n/a | 2.18 (0.6; 3.1) |
| IDA | 41.80 (14; 98) | 8.15 (2.6; 20.9) | 472.11 (424; 535) | 0.33 (0.3; 0.4) |
| IQA | 72.19 (30; 119) | 150.36 (7.2; 674) | n/a | 4.99 (0.4; 18.3) |
| HA | 95.50 (26; 210) | 656.3 (45.1; 4316.3) | n/a | 2.32 (0.6; 4.3) |
| TM | 45.67 (16; 65) | 20.62 (4.9; 40.7) | 349.4 (295; 444) | 0.63 (0.2; 1.5) |
| CKD | 86.86 (37; 176) | 203 (17.5; 756.1) | 274.17 (200; 432) | 0.6 (0.3; 0.8) |
| Other | 110.41 (29; 322) | 698.08 (6.3; 6147.9) | 355.25 (238; 589) | 1.14 (0.8; 2) |
| IDA and IQA | 64.95 (14; 119) | 102.95 (2.6; 674) | 472.11 (424; 535) | 4.16 (0.3; 18.3) |
HS hereditary spherocytosis, IDA iron deficiency anemia, IQA anemia of first quarter of life, HA hemolytic anemia, TM thalassemia minor, CKD chronic kidney disease, n/a not applicable